EP. 1: Case 1: An Elderly Patient With Newly Diagnosed High-Risk CLL
Watch
EP. 2: Case 1: Prognostic Features and Chemoimmunotherapy Treatment Options
EP. 3: Case 1: Targeted Therapy: Ibrutinib for Newly Diagnosed CLL
EP. 4: Case 1: Treatment Decision: Ibrutinib Monotherapy
EP. 5: Case 2: 17p-Deleted CLL Progressing on Ibrutinib Therapy
EP. 6: Case 2: Treatment Options: Venetoclax +/- Rituximab
EP. 7: Case 3: Elderly Patient With CLL, Mutated TP53 and NOTCH, Unmutated IgHV
EP. 8: Case 3: Response to Frontline Therapy and Toxicity Management
EP. 9: Case 3: Progression on Ibrutinib Followed by Richter Transformation
EP. 10: Case 3: Therapeutic Approaches for Richter Transformation
EP. 11: Case 4: A Young, Fit Patient With MRD-Positive CLL After Immunochemotherapy
EP. 12: Case 4: iFCG in Untreated CLL
EP. 13: Case 4: iFCR in Untreated CLL
EP. 14: Case 4: Maintenance Strategies in CLL
